Clinical Trial Update: A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a therapy selected by molecular/metabolic profiling in patients with previously treated metastatic pancreatic cancer has completed. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Translational Drug Development | Conditions: Previously Treated Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED